A role for complement in glaucoma?

Advances in Experimental Medicine and Biology

Volumn 703, Issue , 2010, Pages 95-104

  Ren, Lizhen ^b   Danias, John ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3;

APOPTOSIS; COMPLEMENT ACTIVATION; DISEASE COURSE; GLAUCOMA; HUMAN; INFLAMMATION; MOLECULAR PATHOLOGY; NERVE CELL DEGENERATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RETINA GANGLION CELL; REVIEW; ANIMAL; CELL DEATH; DISEASE MODEL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; IMMUNOMODULATION; MOUSE; PATHOLOGY; PHYSIOLOGY;

ANIMALIA;

ANIMALS; CELL DEATH; COMPLEMENT C1Q; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GLAUCOMA; HUMANS; MICE; NEUROIMMUNOMODULATION; RETINAL GANGLION CELLS;

EID: 79952116706     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-5635-4_7     Document Type: Review

References (75)

1. Anderson DR (2003) Collaborative normal tension glaucoma study. Curr Opin Ophthalmol 14(2):86-90 (Pubitemid 36584227)
2. Anderson MG, Smith RS, Hawes NL, Zabaleta A, Chang B, Wiggs JL, John SW (2002) Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice. Nat Genet 30(1):81-85
3. Anderson MG, Libby RT, Mao M, Cosma IM, Wilson LA, Smith RS, John SW (2006) Genetic context determines susceptibility to intraocular pressure elevation in a mouse pigmentary glaucoma. BMC Biol 4:20
4. Bayer AU, Danias J, Brodie S, Maag KP, Chen B, Shen F, Podos SM, Mittag TW (2001) Electroretinographic abnormalities in a rat glaucoma model with chronic elevated intraocular pressure. Exp Eye Res 72(6):667-677 (Pubitemid 32977213)
5. Beck AD (2003) Review of recent publications of the Advanced Glaucoma Intervention Study. Curr Opin Ophthalmol 14(2):83-85 (Pubitemid 36584226)
6. Bohana-Kashtan O, Ziporen L, Donin N, Kraus S, Fishelson Z (2004) Cell signals transduced by complement. Mol Immunol 41(6-7):583-597 (Pubitemid 38824616)
7. Cedrone C, Mancino R, Cerulli A, Cesareo M, Nucci C (2008) Epidemiology of primary glaucoma: prevalence, incidence, and blinding effects. Prog Brain Res 173:3-14
8. Coleman AL, Brigatti L (2001) The glaucomas. Minerva Med 92(5):365-379 (Pubitemid 33072406)
9. Cordeiro MF, Guo L, Luong V, Harding G, Wang W, Jones HE, Moss SE, Sillito AM, Fitzke FW (2004) Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc Natl Acad Sci U S A 101(36):13352-13356 (Pubitemid 39209669)
10. Danias J, Lee KC, Zamora MF, Chen B, Shen F, Filippopoulos T, Su Y, Goldblum D, Podos SM, Mittag T (2003) Quantitative analysis of retinal ganglion cell (RGC) loss in aging DBA/2NNia glaucomatous mice: comparison with RGC loss in aging C57/BL6 mice. Invest Ophthalmol Vis Sci 44(12):5151-5162 (Pubitemid 37475383)
11. Downs JC, Yang H, Girkin C, Sakata L, Bellezza A, Thompson H, Burgoyne CF (2007) Threedimensional histomorphometry of the normal and early glaucomatous monkey optic nerve head: neural canal and subarachnoid space architecture. Invest Ophthalmol Vis Sci 48(7):3195-3208 (Pubitemid 351261164)
12. Gaipl US, Kuhn A, Sheriff A, Munoz LE, Franz S, Voll RE, Kalden JR, Herrmann M (2006) Clearance of apoptotic cells in human SLE. Curr Dir Autoimmun 9:173-187
13. Gordon MO, Beiser JA, Brandt JD, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish RK II, Wilson MR, Kass MA (2002) The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 120(6):714-720, discussion 829-830 (Pubitemid 34620349)
14. Gullstrand B, Martensson U, Sturfelt G, Bengtsson AA, Truedsson L (2009) Complement classicalpathway components are all important in clearance of apoptotic and secondary necrotic cells. Clin Exp Immunol 156(2):303-311
15. Gupta N, Ly T, Zhang Q, Kaufman PL, Weinreb RN, Yucel YH (2007) Chronic ocular hypertension induces dendrite pathology in the lateral geniculate nucleus of the brain. Exp Eye Res 84(1):176-184 (Pubitemid 44792063)
16. Gupta N, Greenberg G, de Tilly LN, Gray B, Polemidiotis M, Yucel YH (2009) Atrophy of the lateral geniculate nucleus in human glaucoma detected by magnetic resonance imaging. Br J Ophthalmol 93(1):56-60
17. Howell GR, Libby RT, Jakobs TC, Smith RS, Phalan FC, Barter JW, Barbay JM, Marchant JK, Mahesh N, Porciatti V, Whitmore AV, Masland RH, John SW (2007a) Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma. J Cell Biol 179(7):1523-1537
18. Howell GR, Libby RT, Marchant JK, Wilson LA, Cosma IM, Smith RS, Anderson MG, John SW (2007b) Absence of glaucoma in DBA/2J mice homozygous for wild-type versions of Gpnmb and Tyrp1. BMC Genet 8:45
19. Jakobs TC, Libby RT, Ben Y, John SW, Masland RH (2005) Retinal ganglion cell degeneration is topological but not cell type specific in DBA/2J mice. J Cell Biol 171(2):313-325 (Pubitemid 41540023)
20. Jha P, Bora PS, Sohn JH, Kaplan HJ, Bora NS (2006) Complement system and the eye. Adv Exp Med Biol 586:53-62
21. John SW, Smith RS, Savinova OV, Hawes NL, Chang B, Turnbull D, Davisson M, Roderick TH, Heckenlively JR (1998) Essential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice. Invest Ophthalmol Vis Sci 39(6):951-962 (Pubitemid 28196680)
22. Johnson EC, Morrison JC, Farrell S, Deppmeier L, Moore CG, McGinty MR (1996) The effect of chronically elevated intraocular pressure on the rat optic nerve head extracellular matrix. Exp Eye Res 62(6):663-674 (Pubitemid 26201533)
23. Kerrigan LA, Zack DJ, Quigley HA, Smith SD, Pease ME (1997) TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol 115(8):1031-1035 (Pubitemid 27328493)
24. Khalyfa A, Chlon T, Qiang H, Agarwal N, Cooper NG (2007) Microarray reveals complement components are regulated in the serum-deprived rat retinal ganglion cell line. Mol Vis 13:293-308 (Pubitemid 46336470)
25. Kim SJ, Gershov D, Ma X, Brot N, Elkon KB (2003) Opsonization of apoptotic cells and its effect on macrophage and T cell immune responses. Ann N Y Acad Sci 987:68-78 (Pubitemid 36584008)
26. Kuehn MH, Kim CY, Ostojic J, Bellin M, Alward WL, Stone EM, Sakaguchi DS, Grozdanic SD, Kwon YH (2006) Retinal synthesis and deposition of complement components induced by ocular hypertension. Exp Eye Res 83(3):620-628 (Pubitemid 43902783)
27. Lautenschlager I, Hockerstedt K, Meri S (1999) Complement membrane attack complex and protectin (CD59) in liver allografts during acute rejection. J Hepatol 31(3):537-541 (Pubitemid 29408739)
28. Leske MC (2007) Open-angle glaucoma - an epidemiologic overview. Ophthalmic Epidemiol 14(4):166-172 (Pubitemid 47493715)
29. Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E (2003) Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 121(1):48-56 (Pubitemid 36401765)
30. Leske MC, Heijl A, Hyman L, Bengtsson B, Dong L, Yang Z (2007a) Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 114(11):1965-1972 (Pubitemid 350016362)
31. Leske MC, Wu SY, Honkanen R, Nemesure B, Schachat A, Hyman L, Hennis A (2007b) Nineyear incidence of open-angle glaucoma in the Barbados Eye Studies. Ophthalmology 114(6):1058-1064 (Pubitemid 46829370)
32. Levkovitch-Verbin H, Quigley HA, Kerrigan-Baumrind LA, D'Anna SA, Kerrigan D, Pease ME (2001) Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. Invest Ophthalmol Vis Sci 42(5):975-982 (Pubitemid 32289792)
33. Libby RT, Anderson MG, Pang IH, Robinson ZH, Savinova OV, Cosma IM, Snow A, Wilson LA, Smith RS, Clark AF, John SW (2005a) Inherited glaucoma in DBA/2J mice: pertinent disease features for studying the neurodegeneration. Vis Neurosci 22(5):637-648 (Pubitemid 43237759)
34. Libby RT, Li Y, Savinova OV, Barter J, Smith RS, Nickells RW, John SW (2005b) Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet 1(1):17-26
35. Mevorach D (2000) Opsonization of apoptotic cells. Implications for uptake and autoimmunity. Ann N Y Acad Sci 926:226-235 (Pubitemid 32050159)
36. Mittag TW, Danias J, Pohorenec G, Yuan HM, Burakgazi E, Chalmers-Redman R, Podos SM, Tatton WG (2000) Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci 41(11):3451-3459
37. Miyahara T, Kikuchi T, Akimoto M, Kurokawa T, Shibuki H, Yoshimura N (2003) Gene microarray analysis of experimental glaucomatous retina from cynomologous monkey. Invest Ophthalmol Vis Sci 44(10):4347-4356 (Pubitemid 37186269)
38. Morrison JC, Moore CG, Deppmeier LM, Gold BG, Meshul CK, Johnson EC (1997) A rat model of chronic pressure-induced optic nerve damage. Exp Eye Res 64(1):85-96 (Pubitemid 27096643)
39. Muller-Eberhard HJ (1986) The membrane attack complex of complement. Annu Rev Immunol 4:503-528
40. Nemesure B, Honkanen R, Hennis A, Wu SY, Leske MC (2007) Incident open-angle glaucoma and intraocular pressure. Ophthalmology 114(10):1810-1815 (Pubitemid 47483917)
41. Oliver JE, Hattenhauer MG, Herman D, Hodge DO, Kennedy R, Fang-Yen M, Johnson DH (2002) Blindness and glaucoma: a comparison of patients progressing to blindness from glaucoma with patients maintaining vision. Am J Ophthalmol 133(6):764-772 (Pubitemid 34580623)
42. Parrish RK II, Feuer WJ, Schiffman JC, Lichter PR, Musch DC (2009) Five-year follow-up optic disc findings of the Collaborative Initial Glaucoma Treatment Study. Am J Ophthalmol 147(4):717-724.e1
43. Pasinetti GM, Tocco G, Sakhi S, Musleh WD, DeSimoni MG, Mascarucci P, Schreiber S, Baudry M, Finch CE (1996) Hereditary deficiencies in complement C5 are associated with intensified neurodegenerative responses that implicate new roles for the C-system in neuronal and astrocytic functions. Neurobiol Dis 3(3):197-204 (Pubitemid 26391323)
44. Pederson JE, Gaasterland DE (1984) Laser-induced primate glaucoma. I. Progression of cupping. Arch Ophthalmol 102(11):1689-1692 (Pubitemid 15204570)
45. Quigley HA (1995) Ganglion cell death in glaucoma: pathology recapitulates ontogeny. Aust N Z Ophthalmol 23(2):85-91 (Pubitemid 26020790)
46. Rasmussen CA, Kaufman PL (2005) Primate glaucoma models. J Glaucoma 14(4):311-314 (Pubitemid 41023019)
47. Rudnicka AR, Mt-Isa S, Owen CG, Cook DG, Ashby D (2006) Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis. Invest Ophthalmol Vis Sci 47(10):4254-4261 (Pubitemid 46579346)
48. Schlamp CL, Li Y, Dietz JA, Janssen KT, Nickells RW (2006) Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci 7:66
49. Schwartz M (2004) Vaccination for glaucoma: dream or reality? Brain Res Bull 62(6):481-484 (Pubitemid 38253032)
50. Schwartz M (2005) T-cell-based vaccination against neurodegeneration: a new therapeutic approach. Retina 25(8 Suppl):S33-S35 (Pubitemid 44726514)
51. Schwartz M (2007) Modulating the immune system: a vaccine for glaucoma? Can J Ophthalmol 42(3):439-441 (Pubitemid 46932039)
52. Schwartz M, Kipnis J (2005) Therapeutic T cell-based vaccination for neurodegenerative disorders: the role of CD4+CD25+ regulatory T cells. Ann N Y Acad Sci 1051:701-708 (Pubitemid 41362797)
53. Shareef SR, Garcia-Valenzuela E, Salierno A, Walsh J, Sharma SC (1995) Chronic ocular hypertension following episcleral venous occlusion in rats. Exp Eye Res 61(3):379-382
54. Sheldon WG, Warbritton AR, Bucci TJ, Turturro A (1995) Glaucoma in food-restricted and ad libitum-fed DBA/2NNia mice. Lab Anim Sci 45(5):508-518
55. Shields MB (2008) Normal-tension glaucoma: is it different from primary open-angle glaucoma? Curr Opin Ophthalmol 19(2):85-88 (Pubitemid 351322808)
56. Sohn JH, Kaplan HJ, Suk HJ, Bora PS, Bora NS (2000) Chronic low level complement activation within the eye is controlled by intraocular complement regulatory proteins. Invest Ophthalmol Vis Sci 41(11):3492-3502
57. Sommer A, Tielsch JM, Katz J, Quigley HA, Gottsch JD, Javitt J, Singh K (1991) Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey. Arch Ophthalmol 109(8):1090-1095
58. Stasi K, Nagel D, Yang X, Wang RF, Ren L, Podos SM, Mittag T, Danias J (2006) Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Invest Ophthalmol Vis Sci 47(3):1024-1029 (Pubitemid 46768335)
59. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, Micheva KD, Mehalow AK, Huberman AD, Stafford B, Sher A, Litke AM, Lambris JD, Smith SJ, John SW, Barres BA (2007) The classical complement cascade mediates CNS synapse elimination. Cell 131(6):1164-1178 (Pubitemid 350235022)
60. Tezel G (2009) The role of glia, mitochondria, and the immune system in glaucoma. Invest Ophthalmol Vis Sci 50(3):1001-1012
61. Tezel G, Seigel GM, Wax MB (1998) Autoantibodies to small heat shock proteins in glaucoma. Invest Ophthalmol Vis Sci 39(12):2277-2287 (Pubitemid 28485639)
62. Tezel G, Yang X, Luo C, Peng Y, Sun SL, Sun D (2007) Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia. Invest Ophthalmol Vis Sci 48(2):705-714 (Pubitemid 351260704)
63. Thylefors B, Negrel AD (1994) The global impact of glaucoma. Bull World Health Organ 72(3):323-326 (Pubitemid 24232504)
64. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J (1991) Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 266(3):369-374
65. Urcola JH, Hernandez M, Vecino E (2006) Three experimental glaucoma models in rats: comparison of the effects of intraocular pressure elevation on retinal ganglion cell size and death. Exp Eye Res 83(2):429-437 (Pubitemid 43850958)
66. Villalba JM, Navas P (2000) Plasma membrane redox system in the control of stress-induced apoptosis. Antioxid Redox Signal 2(2):213-230 (Pubitemid 30445934)
67. Wax MB (2000) Is there a role for the immune system in glaucomatous optic neuropathy? Curr Opin Ophthalmol 11(2):145-150 (Pubitemid 30164037)
68. Wax MB, Tezel G (2002) Neurobiology of glaucomatous optic neuropathy: diverse cellular events in neurodegeneration and neuroprotection. Mol Neurobiol 26(1):45-55 (Pubitemid 35176866)
69. Weinreb RN, Lindsey JD (2005) The importance of models in glaucoma research. J Glaucoma 14(4):302-304 (Pubitemid 41023016)
70. Wilson MR, Kosoko O, Cowan CL Jr, Sample PA, Johnson CA, Haynatzki G, Enger C, Crandall D (2002) Progression of visual field loss in untreated glaucoma patients and glaucoma suspects in St. Lucia, West Indies. Am J Ophthalmol 134(3):399-405
71. Xiong ZQ, Qian W, Suzuki K, McNamara JO (2003) Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration. J Neurosci 23(3):955-960 (Pubitemid 36206186)
72. Yang H, Downs JC, Bellezza A, Thompson H, Burgoyne CF (2007a) 3-D histomorphometry of the normal and early glaucomatous monkey optic nerve head: prelaminar neural tissues and cupping. Invest Ophthalmol Vis Sci 48(11):5068-5084 (Pubitemid 351260917)
73. Yang H, Downs JC, Girkin C, Sakata L, Bellezza A, Thompson H, Burgoyne CF (2007b) 3-D histomorphometry of the normal and early glaucomatous monkey optic nerve head: lamina cribrosa and peripapillary scleral position and thickness. Invest Ophthalmol Vis Sci 48(10):4597-4607 (Pubitemid 351260977)
74. Yucel Y, Gupta N (2008) Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration. Prog Brain Res 173:465-478
75. Yucel YH, Zhang Q, Gupta N, Kaufman PL, Weinreb RN (2000) Loss of neurons in magnocellular and parvocellular layers of the lateral geniculate nucleus in glaucoma. Arch Ophthalmol 118(3):378-384 (Pubitemid 30152379)